Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (3) , 950-963.e9
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activationArthritis Research & Therapy, 2013
- Pentraxin 3: An Immuno-Regulator in the LungsFrontiers in Immunology, 2013
- IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contractionNature Medicine, 2012
- STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription FactorsJournal of Biological Chemistry, 2011
- Lack of the Long Pentraxin PTX3 Promotes Autoimmune Lung Disease but not Glomerulonephritis in Murine Systemic Lupus ErythematosusPLOS ONE, 2011
- Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5Nature Immunology, 2011
- Allergen Uptake, Activation, and IL-23 Production by Pulmonary Myeloid DCs Drives Airway Hyperresponsiveness in Asthma-Susceptible MicePLOS ONE, 2008
- CD4 T cells: fates, functions, and faultsBlood, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsJournal of Experimental Medicine, 2008
- lnterleukin-2 programs mouse αβ T lymphocytes for apoptosisNature, 1991